ARTICLE | Clinical News
ZnT8Ab ELISA Assay regulatory update
September 1, 2014 7:00 AM UTC
FDA will allow Kronus to market Kronus’ ZnT8Ab ELISA diagnostic, which differentiates Type I diabetes from Type II or gestational diabetes. The blood-based assay detects the autoantibody against solut...